Adult liver disease Flashcards

1
Q

lymphocyte inflammation in hepatitis

A

can be present in many hepatitides; common in VIRAL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

neutrophil inflammation in hepatitis

A

common in steatohepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

eosinophil inflammation in hepatitis

A

common in drug injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

plasma cell inflammation in hepatitis

A

autoimmune hepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

most common cause of chronic liver disease

A

hep C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Labs: evidence of hepatocyte injury

causes: acute viral infection and drug injury
histology: lobular disarray, marked inflammation throughout, widespread hepatocyte injury, NO FIBROSIS

A

acute hepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Causes: chronic viral hepatitis, autoimmune hepatitis, drug injury

histology: less inflammation and injury, portal tract-based inflammation, FIBROSIS

long-standing ( > 6 mo)

A

chronic hepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

can accumulate in hepatocyte cytoplasm during liver injury

A

fat = steatosis
bile = cholestasis
iron = hemosiderosis/genetic hemochromatosis
copper = wilson disease/chronic cholestasis
viral particles = viral hepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ground glass hepatocytes

A

viral infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

process of fibrotic change in hepatocytes

A

chronic cycles of injury/regeneration –> activated stellate cells deposit collagen –> architectural and vascular reorganization –> cirrhosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

On biopsy, “stage” refers to:

A

amount of fibrous tissue deposition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

On biopsy, “grade” refers to:

A

amount of inflammation and injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

transmitted fecal-oral

A

hep A, hep E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

transmitted through parenteral, sexual contact, perinatal routes

A

hep B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

transmitted through parenteral route

A

hep C, hep D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

viruses that can cause chronic liver disease

A

hep C > 80%

hep B = 10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

hep virus diagnosed via PCR

A

hep C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

hep virus diagnosed by presence of surface antigen or antibody to core antigen

A

hep B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what percent of patients who develop cirrhosis secondary to hep C go on to die?

A

50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

major cause of chronic liver disease WORLDWIDE

A

hep B

21
Q

areas with highest prevalence of chronic HBV

A

northern canada, alaska, northern amazon, africa, SE asia

22
Q

what percent of patients infected with HBV go on to develop chronic hepatitis?

A

less than 5%

23
Q

presence of serum HBeAg, HBV-DNA and IgM anti-HBc would signify:

A

acute, active HBV infection

24
Q

presence of serum IgG anti-HBs and IgG anti-HBc

A

chronic HBV infection

25
Q

effect of hep D coinfection with HBV

A

potentiates effects of HBV –> increased risk of fulminant hepatitis, faster progression to end-stage liver disease

26
Q

woman presents with a history of other autoimmune diseases

A

autoimmune hepatitis

27
Q

serology of autoimmune hepatitis

A

autoantibodies (ANA, ASMA, anti-LKMB), elevated IgG

28
Q

plasma cell-rich chronic hepatitis

A

autoimmune hepatitis

29
Q

middle-aged woman presents with pruritus, jaundice; elevated alk phos, GGT, bilirubin

A

primary biliary cirrhosis

30
Q

serology of primary biliary cirrhosis

A

anti-mitochondrial antibody, elevated IgM

31
Q

prognosis of primary biliary cirrhosis

A

25% with liver failure in 10y

32
Q

patient presents with progressive fatigue, pruritus and jaundice. elevated alk phos. history of ulcerative colitis

A

primary sclerosing cholangitis

33
Q

diagnosis of primary sclerosing cholangitis

A

cholangiography –> stenosis of ducts

34
Q

histology: periductal “onion skin” fibrosis

A

primary sclerosing cholangitis

35
Q

what lobule zone is affected by acetaminophen toxicity

A

zone 3 = centrilobular necrosis

36
Q

causes of hepatic steatosis

A

metabolic syndrome (T2DM), alcohol, drugs, Wilson disease, viral infection

37
Q

mechanism of steatosis

A

lipid influx > lipid clearance

38
Q

steatosis with associated hepatocellular injury

A

steatohepatitis

39
Q

mechanism of alcohol steatosis/steatohepatitis

A

increased liplysis and de novo lipogensis from carbs; blocked B oxidation and VLDL generation

40
Q

histology: neutrophilic infiltrates, Mallory bodies

A

alcohol steatosis

41
Q

genetic iron overload disease, throughout the body –> liver disease, diabetes, heart failure

A

hereditary hemochromatosis

42
Q

hereditary hemochromatosis genetics

A

autosomal recessive HFE gene mutations (C282Y and H63D) –> abnormal regulation of Fe absorption

43
Q

genetic copper overload throughout the body –> liver disease, neuropsych sx

A

Wilson disease

44
Q

Wilson disease genetics

A

autosomal recessive mutation in ATP7B gene –> disrupted bile excretion of copper

45
Q

autosomal recessive disease that most often presents with pulmonary emphysema, but can also involve liver disease

A

a1-antitrypsin deficiency

46
Q

normal/abnormal genotypes for alpha-1-antitrypsin

A
normal = PiMM
abnormal = PiZZ
47
Q

histology: PASD stain –> pink globules

A

alpha-1-antitrypsin deficiency

48
Q

malignant liver masses in adults

A

hepatocellular carcinoma, cholangiocarcinoma

49
Q

benign liver masses in adults

A

hemangioma, focal nodular hyperplasia, hepatocellular adenoma